These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 35081892)

  • 1. Preparation of Modified Chitosan-based Nanoparticles for Efficient Delivery of Doxorubicin and/or Cisplatin to Breast Cancer Cells.
    Matalqah SM; Aiedeh K; Mhaidat NM; Alzoubi KH; Al-Husein BA
    Curr Cancer Drug Targets; 2022; 22(2):133-141. PubMed ID: 35081892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line.
    Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA
    Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815
    [No Abstract]   [Full Text] [Related]  

  • 3. Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs.
    Kanwal U; Bukhari NI; Rana NF; Rehman M; Hussain K; Abbas N; Mehmood A; Raza A
    Int J Nanomedicine; 2019; 14():1-15. PubMed ID: 30587981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
    Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
    Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
    Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
    Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
    Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
    Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
    Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Toxicity of Doxorubicin Encapsulated into pH-Responsive Poly(β-Amino Ester)-Functionalized MCM-41 Silica Nanoparticles.
    Ávila-Ortega A; Carrillo-Cocom LM; Olán-Noverola CE; Nic-Can GI; Vilchis-Nestor AR; Talavera-Pech WA
    Curr Drug Deliv; 2020; 17(9):799-805. PubMed ID: 32723272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of anti-HER2-targeted doxorubicin-core-shell chitosan nanoparticles for the treatment of human breast cancer.
    Naruphontjirakul P; Viravaidya-Pasuwat K
    Int J Nanomedicine; 2019; 14():4105-4121. PubMed ID: 31239670
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells.
    Haque ST; Islam RA; Gan SH; Chowdhury EH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937817
    [No Abstract]   [Full Text] [Related]  

  • 11. A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells.
    Cheng B; Lu B; Liu X; Meng T; Tan Y; Zhu Y; Liu N; Yuan H; Huang X; Hu F
    Int J Pharm; 2017 Apr; 522(1-2):210-221. PubMed ID: 28259679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-responsive glycol chitosan-cross-linked carboxymethyl-β-cyclodextrin nanoparticles for controlled release of anticancer drugs.
    Wang Y; Qin F; Tan H; Zhang Y; Jiang M; Lu M; Yao X
    Int J Nanomedicine; 2015; 10():7359-69. PubMed ID: 26677325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of carboplatin and doxorubicin using ZIF-8 coated chitosan-poly(N-isopropyl acrylamide) nanoparticles through a dual pH/thermo responsive strategy to breast cancer cells.
    Dashti N; Akbari V; Varshosaz J; Soleimanbeigi M; Rostami M
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):131971. PubMed ID: 38705336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
    Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of polyelectrolyte complex nanoparticles based on poly (malic acid), chitosan. A pH-dependent delivery system.
    Arif M; Raja MA; Zeenat S; Chi Z; Liu C
    J Biomater Sci Polym Ed; 2017 Jan; 28(1):50-62. PubMed ID: 27691398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
    Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
    Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin/cisplatin co-loaded hyaluronic acid/chitosan-based nanoparticles for in vitro synergistic combination chemotherapy of breast cancer.
    Wang Y; Qian J; Yang M; Xu W; Wang J; Hou G; Ji L; Suo A
    Carbohydr Polym; 2019 Dec; 225():115206. PubMed ID: 31521263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin crosslinked pH-sensitive nanoparticles for efficient delivery of doxorubicin.
    Li M; Tang Z; Lv S; Song W; Hong H; Jing X; Zhang Y; Chen X
    Biomaterials; 2014 Apr; 35(12):3851-64. PubMed ID: 24495487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthesis of folate modified chitosan-based nanomicelles and its
    Liu L; Huang G; Bai H; Tang G
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(3):364-374. PubMed ID: 32762172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin.
    Khan MM; Madni A; Torchilin V; Filipczak N; Pan J; Tahir N; Shah H
    Drug Deliv; 2019 Dec; 26(1):765-772. PubMed ID: 31357896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.